Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies

Drug and Alcohol Review

Volumn 34, Issue 1, 2015, Pages 58-66

  Mccambridge, Jim ^a   Hartwell, Greg ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Alcohol; Alcohol industry; Bias; Cardiovascular disease; Health benefits

Indexed keywords

ALCOHOL;

ALCOHOLIC BEVERAGE; CARDIOVASCULAR DISEASES; ECONOMICS; FINANCIAL MANAGEMENT; FOOD INDUSTRY; HUMAN; MEDICAL RESEARCH; MORTALITY; RISK FACTOR; STANDARDS; STATISTICAL BIAS; STROKE;

ALCOHOLIC BEVERAGES; BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; ETHANOL; FOOD INDUSTRY; HUMANS; RESEARCH SUPPORT AS TOPIC; RISK FACTORS; STROKE;

EID: 84921377294     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12125     Document Type: Article

References (27)

1. Sellman D, Connor J, Robinson G, Jackson R. Alcohol cardio-protection has been talked up. N Z Med J 2009;122:97-101.
2. Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann Epidemiol 2007;17:S16-23.
3. Fekjaer HO. Alcohol-a universal preventive agent? A critical analysis. Addiction 2013;108:2051-2057.
4. Naimi TS, Xuan Z, Brown DW, Saitz R. Confounding and studies of 'moderate' alcohol consumption: the case of drinking frequency and implications for low-risk drinking guidelines. Addiction 2013;108:1534-1543.
5. Fillmore KM, Kerr WC, Stockwell T, Chikritzhs T, Bostrom A. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Addiction Research & Theory 2006;14:101-132.
6. Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction 2012;107:1246-1260.
7. Bero L. Implications of the tobacco industry documents for public health and policy. Annu Rev Publ Health 2003;24:267-288.
8. Poli A, Marangoni F, Avogaro A, etal. Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis 2013;23:487-504.
9. Babor TF, Robaina K. Public health, academic medicine, and the alcohol industry's corporate social responsibility activities. Am J Public Health 2013;103:206-214.
10. Babor TF. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest. Addiction 2009;104(Suppl. 1):34-47.
11. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
12. Goozner M, Caplan A, Moreno J, etal. A common standard for conflict of interest disclosure in addiction journals. Addiction 2009;104:1779-1784.
13. Patra J, Taylor B, Irving H, etal. Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 2010;10:258.
14. Nuesch E, Trelle S, Reichenbach S, etal. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515.
15. Barbour V, Clark J, Jones S, Norton M, Veitch E. Let's be straight up about the alcohol industry. PLoS Med 2011;8:e1001041.
16. Michaels D. Doubt is their product: how industry's assault on science threatens your health. Oxford: Oxford University Press, 2008.
17. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005;2:e138.
18. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 2007;4:e5.
19. Roseman M, Turner EH, Lexchin J, etal. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ 2012;345:e5155.
20. Jernigan DH. Global alcohol producers, science, and policy: the case of the international center for alcohol policies. Am J Public Health 2012;102:80-89.
21. McCambridge J, Hawkins B, Holden C. Industry use of evidence to influence alcohol policy: a case study of submissions to the 2008 Scottish Government consultation. PLoS Med 2013;10:e1001431.
22. McCambridge J, Kypri K, Miller P, Hawkins B, Hastings G. Be aware of drinkaware. Addiction 2013. doi: 10.1111/add.12356.
23. McCambridge J, Hawkins B, Holden C. Vested interests in addiction research and policy: the challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing. Addiction 2014;109:199-205.
24. Francey N, Chapman S. Operation Berkshire': the international tobacco companies' conspiracy. BMJ 2000;321:371-374.
25. Hawkins B, Holden C, McCambridge J. Alcohol industry influence on UK alcohol policy: a new research agenda for public health. Critical Public Health 2012;22:297-305.
26. Daube M. Alcohol and tobacco. Aust N Z J Public Health 2012;36:108-110.
27. Jiang N, Ling P. Vested interests in addiction research and policy. Alliance between tobacco and alcohol industries to shape public policy. Addiction 2013;108:852-864.